Sidoti D, Margotta V, Calosci D, Fiorentini E, Bacci C, Gensini F
Cancers (Basel). 2024; 16(23).
PMID: 39682206
PMC: 11640139.
DOI: 10.3390/cancers16234022.
Buchberg J, de Stricker K, Pfeiffer P, Mortensen M, Detlefsen S
Endosc Ultrasound. 2024; 13(3):154-164.
PMID: 39318643
PMC: 11419524.
DOI: 10.1097/eus.0000000000000072.
Pantaleo A, Forte G, Fasano C, Lepore Signorile M, Sanese P, De Marco K
Cancers (Basel). 2024; 16(1).
PMID: 38201484
PMC: 10778202.
DOI: 10.3390/cancers16010056.
Mukherji R, Yin C, Hameed R, Alqahtani A, Kulasekaran M, He A
Biol Direct. 2022; 17(1):15.
PMID: 35668531
PMC: 9172079.
DOI: 10.1186/s13062-022-00322-0.
Huang J, Chang Y, Hong Z, Lin C
Int J Mol Sci. 2022; 23(6).
PMID: 35328658
PMC: 8952261.
DOI: 10.3390/ijms23063238.
Targeting BRCA and DNA Damage Repair Genes in GI Cancers: Pathophysiology and Clinical Perspectives.
Zimmer K, Kocher F, Puccini A, Seeber A
Front Oncol. 2021; 11:662055.
PMID: 34707985
PMC: 8542868.
DOI: 10.3389/fonc.2021.662055.
Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors.
Klein A
Nat Rev Gastroenterol Hepatol. 2021; 18(7):493-502.
PMID: 34002083
PMC: 9265847.
DOI: 10.1038/s41575-021-00457-x.
Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging.
Morani A, Hanafy A, Ramani N, Katabathina V, Yedururi S, Dasyam A
Radiol Imaging Cancer. 2021; 2(2):e190020.
PMID: 33778702
PMC: 7983791.
DOI: 10.1148/rycan.2020190020.
An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression.
Khan A, Liu X, Yan X, Tahir M, Ali S, Huang H
Cancer Metastasis Rev. 2021; 40(1):245-272.
PMID: 33423164
DOI: 10.1007/s10555-020-09952-0.
Early Diagnosis of Pancreatic Cancer: The Key for Survival.
Gheorghe G, Bungau S, Ilie M, Behl T, Vesa C, Brisc C
Diagnostics (Basel). 2020; 10(11).
PMID: 33114412
PMC: 7694042.
DOI: 10.3390/diagnostics10110869.
BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects.
Wong W, Raufi A, Safyan R, Bates S, Manji G
Cancer Manag Res. 2020; 12:2731-2742.
PMID: 32368150
PMC: 7185320.
DOI: 10.2147/CMAR.S211151.
Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls.
Behl S, Hamel N, de Ladurantaye M, Lepage S, Lapointe R, Mes-Masson A
Sci Rep. 2020; 10(1):6491.
PMID: 32300229
PMC: 7162921.
DOI: 10.1038/s41598-020-63100-w.
Cancer Risks Associated With Germline Pathogenic Variants: An International Study of 524 Families.
Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B
J Clin Oncol. 2019; 38(7):674-685.
PMID: 31841383
PMC: 7049229.
DOI: 10.1200/JCO.19.01907.
Tissue specificity of DNA damage response and tumorigenesis.
Sun S, Osterman M, Li M
Cancer Biol Med. 2019; 16(3):396-414.
PMID: 31565474
PMC: 6743622.
DOI: 10.20892/j.issn.2095-3941.2019.0097.
Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era.
Macedo G, Alemar B, Ashton-Prolla P
Genet Mol Biol. 2019; 42(1 suppl 1):215-231.
PMID: 31067289
PMC: 6687356.
DOI: 10.1590/1678-4685-GMB-2018-0104.
The Fanconi Anemia Pathway in Cancer.
Niraj J, Farkkila A, DAndrea A
Annu Rev Cancer Biol. 2019; 3:457-478.
PMID: 30882047
PMC: 6417835.
DOI: 10.1146/annurev-cancerbio-030617-050422.
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors.
Rawla P, Sunkara T, Gaduputi V
World J Oncol. 2019; 10(1):10-27.
PMID: 30834048
PMC: 6396775.
DOI: 10.14740/wjon1166.
Neuroendocrine Neoplasms Associated with Germline Pathogenic Variants in the Homologous Recombination Pathway.
Szybowska M, Mete O, Weber E, Silver J, Kim R
Endocr Pathol. 2019; 30(3):237-245.
PMID: 30772928
DOI: 10.1007/s12022-019-9569-4.
Familial Pancreatic Ductal Adenocarcinoma.
Diaz K, Lucas A
Am J Pathol. 2018; 189(1):36-43.
PMID: 30558720
PMC: 7073774.
DOI: 10.1016/j.ajpath.2018.06.026.
Inherited pancreatic cancer.
Chen F, Roberts N, Klein A
Chin Clin Oncol. 2018; 6(6):58.
PMID: 29307198
PMC: 5873957.
DOI: 10.21037/cco.2017.12.04.
